Exciting new developments emerge from the oncology and hematology fields constantly. While many changes unfold over time, some announcements, new discoveries, and novel products are unveiled at annual conferences. Major oncology conferences include those of the European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO). Important hematology conferences include the […]

Disease state academies can be a valuable resource for physicians, as they provide educational resources on therapeutic areas relevant to their practice or specialty. Online academies are designed to benefit all involved, helping to implement standards of care as well as novel therapies in today’s clinical practices. With the field of medicine continually evolving and […]

Clinical immersion programs are elective courses that offer continuing education for various life science teams as well as practicing clinicians. These programs are traditionally held in a clinical setting and meant to train attendees on a range of topics, including disease state education, competitive landscape, treatment patterns, and expert perspectives in the management of cancer […]

If you have ever worked for a pharmaceutical company, you’ve likely heard the ubiquitous term “KOL” several dozen times. But do you know what—or rather who—a KOL actually is?

Digital features have become an integral part of many medical publications. While publishers have been adapting to this shift, clinical researchers and pharma in general have been slower to embrace the change. Many authors aren’t sure how to integrate digital features into their publications, or remain unconvinced that these features offer significant benefits. On the […]

Digital features in medical publications are here to stay. These features offer unique benefits that make reading and sharing easier, and less time-consuming. If your organization has been slow to integrate digital features in medical publications, you may be missing out. Read on to learn more about the benefits of digitally enhanced medical publications. Digital Tools […]

As 2019 drew to a close, pharma organizations looked forward to a blockbuster year. Analysts weighed the numbers and made predictions for 2020; but COVID-19 shattered many of their predictions. The global pandemic has led to one of the most tumultuous years in recent memory. There’s no doubt that the pandemic created upheaval in pharma […]

In 2020, COVID-19 had only a minimal effect on drug approvals, which were considerably higher in comparison with 2019. The US Food and Drug Administration (FDA) approved more than 50 new medicines and therapeutic biologics in 2020, more than a third of which were oncology/hematology treatments. Similarly, the European Medicines Agency’s Committee for Medicinal Products […]

Thanks to modern medicine, many cancer patients live longer, healthier lives. These hard-won victories have required a team effort; by working together, life science companies, clinical disease state experts, and community clinicians can dramatically improve cancer care for patients. All 3 entities play a vital role in developing life-saving treatments and ensuring that appropriate patients […]

The medical and pharmaceutical industries are dependent upon access to large amounts of patient data and utilizing this information in their research and the decisions they make regarding drug development and commercialization. Life science companies must continuously sift through mountains of clinical data. They are challenged with placing these data into their proper context to […]